论文信息 - Abstract LB-225: RNA molecular signatures as predictive biomarkers of response to monotherapy pembrolizumab in patients with metastatic triple-negative breast cancer: KEYNOTE-086 - 字舞流文

Abstract LB-225: RNA molecular signatures as predictive biomarkers of response to monotherapy pembrolizumab in patients with metastatic triple-negative breast cancer: KEYNOTE-086

J. Lunceford | Chunsheng Zhang | E. Winer | S. Loi | D. Cescon | V. Karantza | H. Rugo | H. Iwata | S. Adams | A. Tan | R. Cristescu | A. Loboda | R. Nanda | D. Toppmeyer | A. Awada | P. Schmid | J. Cortés | G. Aktan | M. Lane | M. Laurentiis | A. Wang | Andrew Albright